Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Molecular Epidemiology of Birth Defects, |
RCV003154790 | SCV003843724 | likely pathogenic | Ovarian cancer | 2022-01-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004246189 | SCV004883958 | uncertain significance | not specified | 2024-01-16 | criteria provided, single submitter | clinical testing | The c.452T>C (p.L151P) alteration is located in exon 5 (coding exon 5) of the HMMR gene. This alteration results from a T to C substitution at nucleotide position 452, causing the leucine (L) at amino acid position 151 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |